APA (7th ed.) Citation

T, Y. (2023). Editorial Comment on Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study. International journal of urology : official journal of the Japanese Urological Association, 30(9), 721. https://doi.org/10.1111/iju.15146

Chicago Style (17th ed.) Citation

T, Yuasa. "Editorial Comment on Clinical Outcomes of Nivolumab Plus Ipilimumab in Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: Real-world Data from a Japanese Multicenter Retrospective Study." International Journal of Urology : Official Journal of the Japanese Urological Association 30, no. 9 (2023): 721. https://doi.org/10.1111/iju.15146.

MLA (9th ed.) Citation

T, Yuasa. "Editorial Comment on Clinical Outcomes of Nivolumab Plus Ipilimumab in Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: Real-world Data from a Japanese Multicenter Retrospective Study." International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 30, no. 9, 2023, p. 721, https://doi.org/10.1111/iju.15146.